| Name |
CAS |
MF |
MW |
Single-letter sequence |
Three-letter sequence |
Number of AA |
Type |
Inquiry |
| c(RGDyC) |
1206475-79-7 |
C24H34N8O8S |
594.64 |
c(RGDyC) |
Cyclo(Arg-Gly-Asp-D-Tyr-Cys) |
5 |
Tumor-targeting peptide |
|
| c(RGDyK) |
250612-42-1 |
C31H43F6N9O12 |
847.72 |
c(RGDyK) |
cyclo(-Arg-Gly-Asp-d-Phe-Lys-) |
5 |
Tumor-targeting peptide |
|
| CKS9 |
|
C39H66N12O13S2 |
975.15 |
CKSTHPLSC |
Cys–Lys–Ser–Thr–His–Pro–Leu–Ser–Cys |
9 |
M cell-targeting peptide |
|
| CSK |
|
C36H58N12O15S2 |
962.13 |
CSKSSDYQC |
H2N-Cys-Ser-Lys-Ser-Ser-Asp-Tyr-Gln-Cys-COOH |
9 |
|
|
| CTP |
1052692-86-0 |
C64H93N19O19 |
1432.54 |
APWHLSSQYSRT |
H2N-Ala-Pro-Trp-His-Leu-Ser-Ser-Gln-Tyr-Ser-Arg-Thr-OH |
12 |
Cardiac-targeting peptide |
|
| GRGDS |
96426-21-0 |
C17H30N8O9 |
490.46 |
GRGDS |
Gly-Arg-Gly-Asp-Ser |
5 |
M cell-targeting peptide |
|
| GX1 |
|
C33H57N13O15S2 |
940.02 |
CGNSNPKSC |
H2N-Cys-Gly-Asn-Ser-Asn-Pro-Lys-Ser-Cys-COOH |
9 |
Tumor vascular targeting peptide |
|
| HN-1 |
|
C57H96N18O18 |
1321.5 |
TSPLNIHNGQKL |
H2N-Thr-Ser-Pro-Leu-Asn-Ile-His-Asn-Gly-Gln-Lys-Leu-OH |
12 |
Tumor-targeting peptide |
|
| iRGD peptide |
1392278-76-0 |
C35H57N13O14S2 |
948.1 |
c(CRGDKGPDC) |
H2N-Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys-OH |
9 |
|
|
| WL47dimer |
|
C80H130N24O18S4 |
1844.3 |
Chain 1: CSWMRLKChain 2: CSWMRLK |
Chain 1: Cys–Ser–Trp–Met–Arg–Leu–LysChain 2: Cys–Ser–Trp–Met–Arg–Leu–Lys |
14 (7 + 7) |
CAV-1 small molecule ligand |
|
| M2pep |
|
C72H110N21O18 |
1517.8 |
YEQDPWGVKWWY |
H2N-Tyr-Glu-Gln-Asp-Pro-Trp-Gly-Val-Lys-Trp-Trp-Tyr-OH |
13 |
M2 macrophage–targeting peptide |
|
| NGR Peptide 1 |
1926163-30-5 |
C94H174N32O22S2 |
2168.72 |
CNGRCGGKLAKLAKKLAKLAK |
H2N-Cys-Asn-Gly-Arg-Cys-Gly-Gly-DLys-DLeu-DAla-DLys-DLeu-DAla-DLys-DLys-DLeu-DAla-DLys-DLeu-DAla-DLys-NH2(Disulfide Bridge:Cys1-Cys5) |
21 |
Tumor-targeting pro-apoptotic peptide |
|
| RGD |
99896-85-2 |
C12H22N6O6 |
346.3 |
RGD |
H2N-Arg-Gly-Asp-OH |
3 |
|
|
| Cys-SS-31 |
|
C32H56N16O9S |
840.97 |
CDAKF |
H2N-Cys-DArg-Dmt-Lys-Phe-NH2 |
5 |
|
|
| SS-31 |
736992-21-5 |
C32H49N9O5 |
639.8 |
dR-Dmt-K-F-NH2 |
H2N-DArg-Dmt-Lys-Phe-NH2 |
4 |
Mitochondria-targeted antioxidant |
|
| WYRGRL |
|
C37H52N12O8 |
820.92 |
WYRGRL |
H2N-Trp-Tyr-Arg-Gly-Arg-Leu-OH |
6 |
Type II collagen–targeting peptide |
|
| Cyclo(RGDfK) |
161552-03-0 |
C27H41N9O7 |
603.7 |
c(RGDfK) |
cyclo(Arg-Gly-Asp-DPhe-Lys) |
5 |
αvβ3 integrin inhibitor |
|
| DYEMHLWWGTEL |
|
C69H92N16O20S |
1577.66 |
DYEMHLWWGTEL |
H2N-Asp-Tyr-Glu-Met-His-Leu-Trp-Trp-Gly-Thr-Glu-Leu-OH |
12 |
GPC3-targeting peptide |
|
| N3-GE11 |
|
C71H95N19O20 |
1593.72 |
YHWYGYTPQNVI |
Azido-PEG2-CH2CH2CO-Tyr-His-Trp-Tyr-Gly-Tyr-Thr-Pro-Gln-Asn-Val-Ile |
12 |
|
|
| G280-9 |
156761-76-1 |
C44H67N9O15 |
1013.08 |
YLEPGPVTA |
H2N-Tyr-Leu-Glu-Pro-Gly-Pro-Val-Thr-Ala-OH |
9 |
|
|
